<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601827/" ref="ordinalpos=2572&amp;ncbi_uid=4722655&amp;link_uid=PMC3601827" image-link="/pmc/articles/PMC3601827/figure/F5/" class="imagepopup">Figure 5.  From: Corticotropin-releasing factor and noradrenergic <span class="highlight" style="background-color:">signaling</span> exert reciprocal control over startle reactivity. </a></div><br /><div class="p4l_captionBody">Schematic proposing a circuit model of CRF/NE signaling effects on startle reactivity. In this model, CRF1 receptor activation modulates startle by activating two pathways that converge at the nucleus reticularis pontis caudalis (PRC) of the startle circuit. One pathway is the LC-PRC pathway which requires NE release and α1 receptor activation at the PRC. The second pathway, the BNST-PRC pathway, involves CRF1 receptor activation of glutamatergic neurons projecting to the PRC. See text for additional details. Abbreviations: CRF – corticotropin releasing factor; NE – norepinephrine; LC - locus coeruleus; BNST – bed nucleus stria terminalis; GLU – glutamate; PRC: nucleus reticularis pontis caudalis</div></div>